| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SYK | Common Stock | Options Exercise | $442K | +3.61K | +24.2% | $122.51 | 18.5K | Feb 18, 2025 | Direct | |
| transaction | SYK | Common Stock | Tax liability | -$442K | -1.15K | -6.2% | $385.18 | 17.4K | Feb 18, 2025 | Direct | |
| transaction | SYK | Common Stock | Sale | -$942K | -2.46K | -14.16% | $383.07 | 14.9K | Feb 18, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SYK | Stock Option granted 2/8/2017 (right to buy) | Options Exercise | $0 | -3.61K | -100% | $0.00 | 0 | Feb 18, 2025 | Common Stock | 3.61K | $122.51 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $383.0705 to $383.255, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F2 | Stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |